Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Diamyd Biomanufacturing AB
AB
Active
Org 5590410931
Stockholm
Rental and operating of own or leased real estate
·
NACE 6820
Est. 2015 · 10 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Rental and operating of own or leased real estate
/
Diamyd Biomanufacturing AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2022: 0M
0M
2022
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2022
Revenue
478
516
671
201
201
Staff expenses
—
—
—
−0
—
EBITDA
357
1 631
1 015
371
371
Depreciation & amort.
−1 610
−1 318
−1 401
−262
−262
EBIT
−1 253
313
−386
109
109
Net financials
−793
−884
−600
0
−189
Profit before tax
−2 047
−571
−986
−0
−79
Tax
−0
−0
−0
−0
−0
Net profit
−2 047
−571
−986
−0
−79
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2022
Total assets
23 715
24 439
19 907
10 534
10 534
Equity
7 441
4 487
59
435
45
Long-term debt
15 000
18 000
18 000
9 325
9 325
Short-term debt
1 275
1 952
1 849
1 165
1 165
Total debt
16 275
19 952
19 849
10 489
10 490
Financial ratios
5-year trend
EBITDA margin
74,7 %
This company
15,8 %
Market median
This company
Market median
373% above market
2022
2025
Equity ratio
31,4 %
This company
38,2 %
Market median
This company
Market median
18% below market
2022
2025
Return on equity
−27,5 %
This company
18,4 %
Market median
This company
Market median
249% below market
2022
2025
Net profit margin
−428,2 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2022
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2022
2025
Debt / equity
2,19×
This company
0,62×
Market median
This company
Market median
253% above market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-08-31
View
PDF
More on Diamyd Biomanufacturing AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
